PD-L1

Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study
André P Fay, Sabina Signoretti, Marcella Callea, Gabriela H Telό, Rana R McKay, Jiaxi Song, Ingrid Carvo, Megan E Lampron, Marina D Kaymakcalan, Carlos E Poli-de-Figueiredo, Joaquim Bellmunt, F Stephen Hodi, Gordon J Freeman, Aymen Elfiky, Toni K Choueiri

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 3; DOI: 10.1186/s40425-015-0047-3
Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma
Weiqing Jing, Jill A Gershan, James Weber, Dominique Tlomak, Laura McOlash, Catherine Sabatos-Peyton, Bryon D Johnson

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 2; DOI: 10.1186/s40425-014-0043-z
Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer
Raju R Raval, Andrew B Sharabi, Amanda J Walker, Charles G Drake, Padmanee Sharma

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 14; DOI: 10.1186/2051-1426-2-14
Rational combinations of immunotherapeutics that target discrete pathways
Stefani Spranger, Thomas Gajewski

Journal for ImmunoTherapy of Cancer Dec 2013, 1 (1) 16; DOI: 10.1186/2051-1426-1-16

Main menu